- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Ozcabi B, Kirmizibekmez H, Yesiltepe Mutlu G, Dursun F, Guran T
Management of Rapidly Progressive Precocious Puberty in a Patient with Mosaic Turner Syndrome
Acta Endo (Buc) 2021, 17 (1): 101-105doi: 10.4183/aeb.2021.101
Context. Rapidly progressive precocious puberty
(RPPP) is a rare condition in Turner syndrome (TS), with no
consensus on treatment and follow-up. Only 12 cases have
been reported so far.
Objective. We aimed to evaluate the effects of
the GnRH analog (GnRHa) on growth and anti-mullerian
hormone (AMH) levels in TS and RPPP.
Design. The clinical and laboratory data was
recorded at baseline and after treatment.
Subjects and methods. An 8.1-year old girl with a
karyotype of 45, X/46, XX presented with breast development
at Tanner stage-2. Breast development advanced to Tanner
stage-3 at the age of 8.7 years. Growth velocity (GV) was 8
cm/year. Bone age was 11 years with a predicted adult height
of 152 cm. Luteinizing hormone (LH) was 1.69mIU/mL
and estradiol was 33pg/mL, confirming the central puberty.
AMH level was 6.33ng/mL. The sizes of ovaries and uterus
were compatible with the pubertal stage, with an endometrial
thickness of 5 mm. GnRHa was started for RPPP.
Results. After three months, GV declined to 0 cm/3
months and AMH level to 50% of the baseline. Growth
hormone (GH) treatment was started for insufficient growth.
GV improved with GH treatment, as well as a far more
decreased AMH level.
Conclusion. GV usually declines before puberty
in patients with TS, even if the mid-parental height is tall.
RPPP should be considered if GV is increased. Excessive
suppression of growth may be prevented with GH treatment.
GnRHa treatment also plays a role in reducing AMH levels
in patients with TS.
Keywords: GnRH analog, Rapidly progressive
precocious puberty, Turner syndrome.
Correspondence: Bahar Ozcabi, Istanbul Yeni Yuzyil University School of Medicine Gaziosmanpasa Hospital, Department of Pediatrics,
Division of Pediatric Endocrinology, Çukurçesme Cd. 5 Posta kodu: 34245 Gaziosmanpasa, Istanbul, Turkey, E-mail: taskinbahar79@yahoo.com